Santa Fe Precision Oncology Symposium

Santa Fe, NM US
October 19, 2024

This accredited continuing education activity, Santa Fe Precision Oncology Symposium, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.
This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive question and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties. 

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

 

ORGANIZING COMMITTEE: 

Course Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair:

Fei Gu, MD, PhD - Nexus Health

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review the current and emerging paradigms in precision oncology and plan precision-guided management of various malignancies.
  • Explain the roles, advantages, and disadvantages of different testing methodologies for guiding targeted therapies, including the appropriate timing for these tests.
  • Interpret the concept of “tumor agnostic” therapeutics and identify opportunities to optimize treatment logistics and manage side effects across different malignancies.
  • Identify collaboration opportunities among regional providers to optimize patient care through enhanced access to clinical trials available at cancer centers in the region.

HOTEL INFORMATION

A limited number of guestrooms are reserved at the Hilton Santa Fe Historic Plaza for the participants of this meeting at a discounted rate of $229.00 per night. The room rate does not include any additional fees or applicable taxes.

CUTOFF - Thursday, September 26, 2024

Please use the link below to reserve your room for the discounted rate. The rate is good through Thursday, September 26, 2024.

https://group.hilton.com/xzfqzj

Central Reservations number: 1.800.445.8667

If you call into central reservations to reserve the room, please refer to SF PRECISION. 

Parking

$22.00 per vehicle

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 7.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
Course opens: 
05/06/2024
Course expires: 
01/19/2025
Event starts: 
10/19/2024 - 8:00am PDT
Event ends: 
10/19/2024 - 5:00pm PDT
Cost:
$150.00

OCTOBER 19, 2024

All times are listed in Mountain Daylight Time (MDT)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


07:30 AM – 07:35 AM  Welcome

07:35 AM – 08:00 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


08:00 AM – 09:00 AM  Session 1 - NGS & Beyond: Tools in Precision Oncology

Session Chair: Mohammad Vasef, MD

08:00 AM – 08:20 AM  Tissue-Based NGS Testing - Y. Lynn Wang, MD, PhD, FCAP

08:20 AM – 08:40 AM  Liquid Biopsy and ctDNA - Jordan Paul Redemann, MD

08:40 AM – 09:00 AM  Case-Based Discussion - Mohammad Vasef, MD


09:00 AM – 10:30 AM  Session 2 - Targeted Therapies

Session Chair: Ethan Binder, MD

09:00 AM – 09:20 AM  Acute Leukemia: Where Do We Stand Now? - Musa Yilmaz, MD

09:20 AM – 09:40 AM  Receptor Tyrosine Kinases: The NSCLC Story - Moises Harari Turquie, MD

09:40 AM – 10:00 AM  The Hormonal Pathway and Overcoming Humoral Resistance: The HR+HER2- Story - Mei Wei, MD

10:00 AM – 10:30 AM  Case-Based Discussion - Ines Sanchez-Rivera, MD


10:30 AM – 11:00 AM  Break & Exhibits


11:00 AM – 12:00 PM  Session 3 - Tumor Agnostic Treatment

Session Chair: Scott M. Herbert, MD

11:00 AM – 11:30 AM  Keynote Speech - Clifton ‘Kip’ Layman, DO

11:30 AM – 12:00 PM  Panel Discussion - Mei Wei, MD, Scott M. Herbert, MD & Clifton ‘Kip’ Layman, DO


12:00 PM – 01:00 PM  Lunch & Exhibits


01:00 PM – 02:00 PM  Session 4 - Therapeutic Antibodies

Session Chair: Shashank Cingam, MD

01:00 PM – 01:20 PM  Enfortumab in Bladder Cancer - Charles Jiang, MD, MPH

01:20 PM – 01:40 PM  Bispecific Antibodies: Opportunities and Challenges - Adeel Khan, MD, MPH, MS

01:40 PM – 02:00 PM  Panel Discussion/Q&A


02:00 PM – 03:00 PM  Session 5 - Precision Oncology: Focus on Delivery

Session Chair: Malcolm Purdy, MD

02:00 PM – 02:20 PM  IO in Early Stage Cancers - Shiruyeh Schokrpur, MD, PhD

02:20 PM – 02:40 PM  Radionuclide in Diagnosis and Therapy - Anna-Maria Alicia De Costa, MD, PhD

02:40 PM – 03:00 PM  Panel Discussion/Q&A


03:00 PM – 03:30 PM   Break & Exhibits


03:30 PM – 04:30 PM  Session 6 - Managing Toxicities

Session Chair: Neda Hashemi, MD

03:30 PM – 03:50 PM  Managing Side Effects in Oral Oncolytics - Jessica M. Lewis-Gonzalez, PharmD, BCOP &  Mary T. Young, PharmD

03:50 PM – 04:10 PM  Managing Toxicities of ADCs - Katherine Sanchez, MD

04:10 PM – 04:30 PM  Panel Discussion/Q&A


04:30 PM – 05:15 PM  Session 7 - Access to Clinical Trials

Session Chair: Bryan Goss, MD

04:30 PM – 04:45 PM  Clinical Trial Design and Endpoints in the Era of Precision Oncology - Weijing Sun, MD, FACP

04:45 PM – 05:15 PM  Panel Discussion - Gregg E. Franklin MD, PhD, Cheryl Sampson MBA, Clifton ‘Kip’ Layman, DO, Bryan Goss, MD


05:15 PM  Adjourn

Hilton Santa Fe Historic Plaza
100 Sandoval St
Santa Fe, NM 87501
United States

 

HOTEL INFORMATION

A limited number of guestrooms are reserved at the Hilton Santa Fe Historic Plaza for the participants of this meeting at a discounted rate of $229.00 per night. The room rate does not include any additional fees or applicable taxes.

CUTOFF - Thursday, September 26, 2024

Please use the link below to reserve your room for the discounted rate. The rate is good through Thursday, September 26, 2024.

https://group.hilton.com/xzfqzj

Central Reservations number: 1.800.445.8667

If you call into central reservations to reserve the room, please refer to SF PRECISION. 

Parking

$22.00 per vehicle

 

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Conference Chair(s)

Fei Gu, MD PhD

has no relevant financial relationships to disclose at this time.
Session Chair(s)

Ethan Binder, MD

has no relevant financial relationships to disclose at this time.

Shashank Cingam

has no relevant financial relationships to disclose at this time.

Bryan Goss, MD

has no relevant financial relationships to disclose at this time.

Neda Hashemi

has a financial relationship (Other) with Eisai;.

Scott Herbert

has no relevant financial relationships to disclose at this time.

Malcolm Purdy

has no relevant financial relationships to disclose at this time.

Mohammad Vasef, Academic pathologist, board certified by American Board of Pathology in AP/CP, Hematopathology, and Molecular Genetic Pathology

has a financial relationship (Professional Services) with Roche Diagnostics;.
Speaker/Topic Presenter(s)

Anna-Maria De Costa, MD, PhD

has no relevant financial relationships to disclose at this time.

Moises Harari Turquie, MD

has no relevant financial relationships to disclose at this time.

Changchuan(Charles) Jiang, MD, MPH

has no relevant financial relationships to disclose at this time.

Adeel Khan, Adeel Khan, MD, MPH, MS

has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Sanofi;.

Clifton 'Kip' Layman, DO

has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Independent contractor) with Karyopharm;.
has a financial relationship (Independent contractor) with Astra Zeneca;.
has a financial relationship (Independent contractor) with Daiichi Sankyo;.
has a financial relationship (Independent contractor) with Bristol Myers Squibb;.
has a financial relationship (Independent contractor) with Sanofi;.

Jessica Lewis-Gonzalez, PharmD, BCOP

has no relevant financial relationships to disclose at this time.

Jordan Redemann, MD

has no relevant financial relationships to disclose at this time.

Katherine Sanchez, MD

has no relevant financial relationships to disclose at this time.

Shiruyeh Schokrpur, M.D., Ph.D.

has no relevant financial relationships to disclose at this time.

Weijing Sun

has a financial relationship (Professional Services) with astra zeneca;.
has a financial relationship (Professional Services) with Ipsen;.
has a financial relationship (Professional Services) with Merk;.

Y. Wang

has no relevant financial relationships to disclose at this time.

Mei Wei, MD

has a financial relationship (Other) with Astrazeneca;.
has a financial relationship (Other) with Relay therapeutics;.
has a financial relationship (Other) with Seagen;.
has a financial relationship (Other) with Arvinas;.
has a financial relationship (Other) with Novartis;.

Musa Yilmaz

has no relevant financial relationships to disclose at this time.

Mary Young, PharmD, BCOP

has a financial relationship (Other) with Precision AQ;.
Case Presenter(s)

Gregg Franklin, MD, PhD

has a financial relationship (Other) with BAYER;.

Cheryl Sampson, CCRP, MBA

has no relevant financial relationships to disclose at this time.

Ines Sanchez Rivera, Area and Regional Medical Director Of Texas Oncology El Paso

has no relevant financial relationships to disclose at this time.

Mohammad Vasef, Academic pathologist, board certified by American Board of Pathology in AP/CP, Hematopathology, and Molecular Genetic Pathology

has a financial relationship (Professional Services) with Roche Diagnostics;.

Acknowledgement of Commercial Support

This activity is supported with an Independent Medical Education Grant from Novartis

Available Credit

  • 7.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
NameSponsorship typeRequester  Name2nd Rep  Name
Menarini StemlineTabletop ExhibitAngela Cacciatore McLaughlinKris Prasse
MerckCHARGING STATIONJames Paz 
GileadTabletop ExhibitMary Jo ChavezBetty Novack
BiotheranosticsTabletop ExhibitMari Sickler 
EisaiTabletop ExhibitMark Neally 
AstrazenecaTabletop ExhibitKimberly Kathleen GallegosFred Visci
Kite PharmaTabletop ExhibitDenise Puentes 
JNJTabletop ExhibitBea NaveretteAdelita Dimas
GenmabTabletop ExhibitJodi GloverStephanie Willoughby
NovartisTabletop ExhibitJames Bandy 
BMS (Bristol Myers Squibb)Tabletop ExhibitBrenda Gossage 
PfizerTabletop ExhibitCheryl Lynn BaileyTracy Feldman
BeigeneTabletop ExhibitNikki QuinlanHeather Grove
Lilly OncologyNO TABLE NEEDEDAshish Suthar, PharmD, MJ 

 

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.